Video

Dr Jeff Patton: How OneOncology Will Support Patients Throughout the Continuum of Care

Through OneOncology, we will be able to identify best practices and support patients throughout the continuum of care, explained Jeff Patton, MD, chief executive officer of Tennessee Oncology.

Through OneOncology, we will be able to identify best practices and support patients throughout the continuum of care, explained Jeff Patton, MD, chief executive officer of Tennessee Oncology.

Transcript

How will partnerships through OneOncology better help community practices support patients throughout the entire continuum of care?

We’re going to use best practices from our best practices, is 1. Number 2, we’ve all learned a lot about how to provide better care to patients in the Oncology Care Model. I think focusing on the patient experience throughout the continuum of care is something we’re really focused on, but it really is identifying best practices and then communicating that across the network. It’s one of the secret sauces of what we’re building at OneOncology.

What do you think the future holds for OneOncology?

I’m excited about the future, and so, change is opportunity as far as I’m concerned and we’re concerned. That’s why we started OneOncology. We founded OneOncology so that we can impact the future, hopefully build a network across the nation that will change the way cancer care is delivered in the country

Related Videos
Picture of San Diego skyline with words ASH Annual Meeting 2024 and health icons overlaid on the bottom
Screenshot of an interview with Amir Ali, PharmD, BCOP
Mansi Shah, MD, assistant professor, Rutgers Cancer Institute of New Jersey
 Alvaro Alencar, MD, associate professor of clinical medicine, chief medical officer, University of Miami Sylvester Comprehensive Cancer Center
Dr Cesar Davila-Chapa
Screenshot of an interview with Nadine Barrett, PhD
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Mabel Mardones, MD.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo